Best Practice & Research Clinical Rheumatology
Volume 22, Issue 1 , Pages 113-127 , March 2008

Hypophosphatasia

  • Etienne Mornet, PhD (Assistant Professor in Genetics at the University of Versailles-Saint Quentin en Yvelines and Co-director of the SESEP laboratory (Versailles Hospital))

      Affiliations

    • Corresponding Author InformationLaboratoire SESEP, Centre Hospitalier de Versailles, Bâtiment EFS, 2 rue Jean-Louis Forain, 78150 Le Chesnay, France. Tel.: +33 1 39 63 80 13; Fax: +33 1 39 63 80 12.

References 

  1. Whyte MP. Hypophosphatasia and the role of alkaline phosphatase in skeletal mineralization. Endocrine Reviews. 1994;15:439–461
  2. Moore CA, Curry CJ, Henthorn PS, et al. Mild autosomal dominant hypophosphatasia: in utero presentation in two families. American Journal of Medical Genetics. 1999;86:410–415
  3. Pauli RM, Modaff P, Sipes SL, Whyte MP. Mild hypophosphatasia mimicking severe osteogenesis imperfecta in utero: bent but not broken. American Journal of Medical Genetics. 1999;86:434–438
  4. Sinico M, Levaillant JM, Vergnaud A, et al. Specific osseous spurs in a lethal form of hypophosphatasia correlated with 3D prenatal ultrasonographic images. Prenatal Diagnosis. 2007;27:222–227
  5. Wenkert D, McAlister WH, Coburn S, et al. Non-lethal hypophosphatasia interpreted as severe skeletal dysplasia in utero.In : Fifth international alkaline phosphatase symposium: ‘understanding alkaline phosphatase function – pathophysiology and treatment of hypophosphatasia and other AP-related diseases’. Huningue, France; 2007.
  6. Whyte MP, Magill HL, Fallon MD, Herrod HG. Infantile hypophosphatasia: normalization of circulating bone alkaline phosphatase activity followed by skeletal remineralization. Evidence for an intact structural gene for tissue nonspecific alkaline phosphatase. The Journal of Pediatrics. 1986;108:82–88
  7. Cole DEC. Hypophosphatasia. Amsterdam: Academic Press; 2003;
  8. Fallon MD, Teitelbaum SL, Weinstein RS, et al. Hypophosphatasia: clinicopathologic comparison of the infantile, childhood, and adult forms. Medicine (Baltimore). 1984;63:12–24
  9. Kozlowski K, Sutcliffe J, Barylak A, et al. Hypophosphatasia. Review of 24 cases. Pediatric Radiology. 1976;5:103–117
  10. Whyte MP, Teitelbaum SL, Murphy WA, et al. Adult hypophosphatasia. Clinical, laboratory, and genetic investigation of a large kindred with review of the literature. Medicine (Baltimore). 1979;58:329–347
  11. Beumer J, Trowbridge HO, Silverman S, Eisenberg E. Childhood hypophosphatasia and the premature loss of teeth. A clinical and laboratory study of seven cases. Oral Surgery Oral Medicine Oral Pathology. 1973;35:631–640
  12. Schwartz JH, Lipmann F. Phosphate incorporation into alkaline phosphatase of E. coli. Proceedings of the National Academy of Sciences of the United States of America. 1961;47:1996–2005
  13. Kim EE, Wyckoff HW. Reaction mechanism of alkaline phosphatase based on crystal structures. Two-metal ion catalysis. Journal of Molecular Biology. 1991;218:449–464
  14. Hawrylak K, Stinson RA. Tetrameric alkaline phosphatase from human liver is converted to dimers by phosphatidylinositol phospholipase C. FEBS Letters. 1987;212:289–291
  15. Stigbrand T. Present status and future trends of human alkaline phosphatases. Progress in Clinical and Biological Research. 1984;166:3–14
  16. Millan JL. Alkaline phosphatase as a reporter of cancerous transformation. Clinica Chimica Acta. 1992;209:123–129
  17. Greenberg CR, Evans JA, McKendry-Smith S, et al. Infantile hypophosphatasia: localization within chromosome region 1p36.1-34 and prenatal diagnosis using linked DNA markers. American Journal of Human Genetics. 1990;46:286–292
  18. Zurutuza L, Muller F, Gibrat JF, et al. Correlations of genotype and phenotype in hypophosphatasia. Human Molecular Genetics. 1999;8:1039–1046
  19. Le Du MH, Stigbrand T, Taussig MJ, et al. Crystal structure of alkaline phosphatase from human placenta at 1.8 A resolution. Implication for a substrate specificity. The Journal of Biological Chemistry. 2001;276:9158–9165
  20. Le Du MH, Millan JL. Structural evidence of functional divergence in human alkaline phosphatases. The Journal of Biological Chemistry. 2002;277:49808–49814
  21. Mornet E, Stura E, Lia-Baldini AS, et al. Structural evidence for a functional role of human tissue nonspecific alkaline phosphatase in bone mineralization. The Journal of Biological Chemistry. 2001;276:31171–31178
  22. Hoylaerts MF, Ding L, Narisawa S, et al. Mammalian alkaline phosphatase catalysis requires active site structure stabilization via the N-terminal amino acid microenvironment. Biochemistry. 2006;45:9756–9766
  23. Kozlenkov A, Le Du MH, Cuniasse P, et al. Residues determining the binding specificity of uncompetitive inhibitors to tissue-nonspecific alkaline phosphatase. Journal of Bone and Mineral Research. 2004;19:1862–1872
  24. Bossi M, Hoylaerts MF, Millan JL. Modifications in a flexible surface loop modulate the isozyme-specific properties of mammalian alkaline phosphatases. The Journal of Biological Chemistry. 1993;268:25409–25416
  25. Hoylaerts MF, Manes T, Millan JL. Mammalian alkaline phosphatases are allosteric enzymes. The Journal of Biological Chemistry. 1997;272:22781–22787
  26. Hoylaerts MF, Millan JL. Site-directed mutagenesis and epitope-mapped monoclonal antibodies define a catalytically important conformational difference between human placental and germ cell alkaline phosphatase. European Journal of Biochemistry. 1991;202:605–616
  27. Vittur F, Stagni N, Moro L, de Bernard B. Alkaline phosphatase binds to collagen: a hypothesis on the mechanism of extravesicular mineralization in epiphyseal cartilage. Experientia. 1984;40:836–837
  28. Wu LN, Genge BR, Lloyd GC, Wuthier RE. Collagen-binding proteins in collagenase-released matrix vesicles from cartilage. Interaction between matrix vesicle proteins and different types of collagen. The Journal of Biological Chemistry. 1991;266:1195–1203
  29. Millan J. Mammalian alkaline phosphatases: from biology to applications in medicine and biotechnology. Weinheim: Wiley-VCH Verlag GmbH; 2006;
  30. Fallon MD, Whyte MP, Teitelbaum SL. Stereospecific inhibition of alkaline phosphatase by l-tetramisole prevents in vitro cartilage calcification. Laboratory Investigation. 1980;43:489–494
  31. Meyer JL. Can biological calcification occur in the presence of pyrophosphate?. Archives of Biochemistry and Biophysics. 1984;231:1–8
  32. Rezende AA, Pizauro JM, Ciancaglini P, Leone FA. Phosphodiesterase activity is a novel property of alkaline phosphatase from osseous plate. Biochemical Journal. 1994;301(Pt 2):517–522
  33. Hessle L, Johnson KA, Anderson HC, et al. Tissue-nonspecific alkaline phosphatase and plasma cell membrane glycoprotein-1 are central antagonistic regulators of bone mineralization. Proceedings of the National Academy of Sciences of the United States of America. 2002;99:9445–9449
  34. Ho AM, Johnson MD, Kingsley DM. Role of the mouse ank gene in control of tissue calcification and arthritis. Science. 2000;289:265–270
  35. Harmey D, Hessle L, Narisawa S, et al. Concerted regulation of inorganic pyrophosphate and osteopontin by akp2, enpp1, and ank: an integrated model of the pathogenesis of mineralization disorders. American Journal of Pathology. 2004;164:1199–1209
  36. Litmanovitz , Reish O, Dolfin T, et al. Glu274Lys/Gly309Arg mutation of the tissue-nonspecific alkaline phosphatase gene in neonatal hypophosphatasia associated with convulsions. Journal of Inherited Metabolic Disease. 2002;25:35–40
  37. Baumgartner-Sigl S, Haberlandt E, Mumm S, et al. Pyridoxine-responsive seizures as the first symptom of infantile hypophosphatasia caused by two novel missense mutations (c.677T>C, p.M226T; c.1112C>T, p.T371I) of the tissue-nonspecific alkaline phosphatase gene. Bone. 2007;40:1655–1661
  38. Nunes ML, Mugnol F, Bica I, Fiori RM. Pyridoxine-dependent seizures associated with hypophosphatasia in a newborn. Journal of Child Neurology. 2002;17:222–224
  39. Whyte M. Hypophosphatasia. New York: McGraw-Hill; 2001;
  40. Baxter P. Pyridoxine-dependent seizures: a clinical and biochemical conundrum. Biochimica et Biophysica Acta. 2003;1647:36–41
  41. Waymire KG, Mahuren JD, Jaje JM, et al. Mice lacking tissue non-specific alkaline phosphatase die from seizures due to defective metabolism of vitamin B-6. Nature Genetics. 1995;11:45–51
  42. Thompson MD, Killoran A, Percy ME, et al. Hyperphosphatasia with neurologic deficit: a pyridoxine-responsive seizure disorder?. Pediatric Neurology. 2006;34:303–307
  43. Fonta C, Negyessy L, Renaud L, Barone P. Areal and subcellular localization of the ubiquitous alkaline phosphatase in the primate cerebral cortex: evidence for a role in neurotransmission. Cerebral Cortex. 2004;14:595–609
  44. Fonta C, Negyessy L, Renaud L, Barone P. Postnatal development of alkaline phosphatase activity correlates with the maturation of neurotransmission in the cerebral cortex. The Journal of Comparative Neurology. 2005;486:179–196
  45. Di Mauro S, Manes T, Hessle L, et al. Kinetic characterization of hypophosphatasia mutations with physiological substrates. Journal of Bone and Mineral Research. 2002;17:1383–1391
  46. Weiss MJ, Ray K, Henthorn PS, et al. Structure of the human liver/bone/kidney alkaline phosphatase gene. The Journal of Biological Chemistry. 1988;263:12002–12010
  47. Terao M, Studer M, Gianni M, Garattini E. Isolation and characterization of the mouse liver/bone/kidney-type alkaline phosphatase gene. Biochemical Journal. 1990;268:641–648
  48. Matsuura S, Kishi F, Kajii T. Characterization of a 5′-flanking region of the human liver/bone/kidney alkaline phosphatase gene: two kinds of mRNA from a single gene. Biochemical and Biophysical Research. 1990;168:993–1000
  49. Studer M, Terao M, Gianni M, Garattini E. Characterization of a second promoter for the mouse liver/bone/kidney-type alkaline phosphatase gene: cell and tissue specific expression. Biochemical and Biophysical Research. 1991;179:1352–1360
  50. Weiss MJ, Cole DE, Ray K, et al. A missense mutation in the human liver/bone/kidney alkaline phosphatase gene causing a lethal form of hypophosphatasia. Proceedings of the National Academy of Sciences of the United States of America. 1988;85:7666–7669
  51. Spentchian M, Brun-Heath I, Taillandier A, et al. Characterization of missense mutations and large deletions in the ALPL gene by sequencing and quantitative multiplex PCR of short fragments. Genetic Testing. 2006;10:252–257
  52. Taillandier A, Sallinen SL, Brun-Heath I, et al. Childhood hypophosphatasia due to a de novo missense mutation in the tissue-nonspecific alkaline phosphatase gene. The Journal of Clinical Endocrinology and Metabolism. 2005;90:2436–2439
  53. Michigami T, Uchihashi T, Suzuki A, et al. Common mutations F310L and T1559del in the tissue-nonspecific alkaline phosphatase gene are related to distinct phenotypes in Japanese patients with hypophosphatasia. European Journal of Pediatrics. 2005;164:277–282
  54. Herasse M, Spentchian M, Taillandier A, Mornet E. Evidence of a founder effect for the tissue-nonspecific alkaline phosphatase (TNSALP) gene E174K mutation in hypophosphatasia patients. European Journal of Human Genetics. 2002;10:666–668
  55. Greenberg CR, Taylor CL, Haworth JC, et al. A homoallelic Gly317-->Asp mutation in ALPL causes the perinatal (lethal) form of hypophosphatasia in Canadian mennonites. Genomics. 1993;17:215–217
  56. Mumm S, Wenkert D, Zhang X et al. Hypophosphatasia: the c.1133A>T, D378V transversion is the most common American TNSALP mutation. In: Fifth international alkaline phosphatase symposium: ‘understanding alkaline phosphatase function – pathophysiology and treatment of hypophosphatasia and other AP-related diseases’. Huningue, France; 2007.
  57. Whyte MP, Essmyer K, Geimer M, Mumm S. Homozygosity for TNSALP mutation 1348c > T (Arg433Cys) causes infantile hypophosphatasia manifesting transient disease correction and variably lethal outcome in a kindred of black ancestry. The Journal of Pediatrics. 2006;148:753–758
  58. Brun-Heath I, Taillandier A, Serre JL, Mornet E. Characterization of 11 novel mutations in the tissue non-specific alkaline phosphatase gene responsible for hypophosphatasia and genotype–phenotype correlations. Molecular Genetics and Metabolism. 2005;84:273–277
  59. Lia-Baldini AS, Muller F, Taillandier A, et al. A molecular approach to dominance in hypophosphatasia. Human Genetics. 2001;109:99–108
  60. Taillandier A, Lia-Baldini AS, Mouchard M, et al. Twelve novel mutations in the tissue-nonspecific alkaline phosphatase gene (ALPL) in patients with various forms of hypophosphatasia. Human Mutation. 2001;18:83–84
  61. Taillandier A, Cozien E, Muller F, et al. Fifteen new mutations (-195C>T, L-12X, 298-2A>G, T117N, A159T, R229S, 997+2T>A, E274X, A331T, H364R, D389G, 1256delC, R433H, N461I, C472S) in the tissue-nonspecific alkaline phosphatase (TNSALP) gene in patients with hypophosphatasia. Human Mutation. 2000;15:293
  62. Orimo H, Girschick HJ, Goseki-Sone M, et al. Mutational analysis and functional correlation with phenotype in German patients with childhood-type hypophosphatasia. Journal of Bone and Mineral Research. 2001;16:2313–2319
  63. Cai G, Michigami T, Yamamoto T, et al. Analysis of localization of mutated tissue-nonspecific alkaline phosphatase proteins associated with neonatal hypophosphatasia using green fluorescent protein chimeras. The Journal of Clinical Endocrinology and Metabolism. 1998;83:3936–3942
  64. Shibata H, Fukushi M, Igarashi A, et al. Defective intracellular transport of tissue-nonspecific alkaline phosphatase with an Ala162-->Thr mutation associated with lethal hypophosphatasia. Journal of Biochemistry (Tokyo). 1998;123:968–977
  65. Sugimoto N, Iwamoto S, Hoshino Y, Kajii E. A novel missense mutation of the tissue-nonspecific alkaline phosphatase gene detected in a patient with hypophosphatasia. Journal of Human Genetics. 1998;43:160–164
  66. Fukushi M, Amizuka N, Hoshi K, et al. Intracellular retention and degradation of tissue-nonspecific alkaline phosphatase with a Gly317-->Asp substitution associated with lethal hypophosphatasia. Biochemical and Biophysical Research. 1998;246:613–618
  67. Watanabe H, Goseki-Sone M, Orimo H, et al. Function of mutant (G1144A) tissue-nonspecific ALP gene from hypophosphatasia. Journal of Bone and Mineral Research. 2002;17:1945–1948
  68. Ishida Y, Komaru K, Ito M, et al. Tissue-nonspecific alkaline phosphatase with an Asp(289)-->Val mutation fails to reach the cell surface and undergoes proteasome-mediated degradation. Journal of Biochemistry (Tokyo). 2003;134:63–70
  69. Ito M, Amizuka N, Ozawa H, Oda K. Retention at the cis-Golgi and delayed degradation of tissue-non-specific alkaline phosphatase with an Asn153-->Asp substitution, a cause of perinatal hypophosphatasia. Biochemical Journal. 2002;361(Pt 3):473–480
  70. Watanabe H, Takinami H, Goseki-Sone M, et al. Characterization of the mutant (A115V) tissue-nonspecific alkaline phosphatase gene from adult-type hypophosphatasia. Biochemical and Biophysical Research. 2005;327:124–129
  71. Fukushi-Irie M, Ito M, Amaya Y, et al. Possible interference between tissue-non-specific alkaline phosphatase with an Arg54-->Cys substitution and acounterpart with an Asp277-->Ala substitution found in a compound heterozygote associated with severe hypophosphatasia. Biochemical Journal. 2000;348(Pt 3):633–642
  72. Komaru K, Ishida Y, Amaya Y, et al. Novel aggregate formation of a frame-shift mutant protein of tissue-nonspecific alkaline phosphatase is ascribed to three cysteine residues in the C-terminal extension. Retarded secretion and proteasomal degradation. The FEBS Journal. 2005;272:1704–1717
  73. Nasu M, Ito M, Ishida Y, et al. Aberrant interchain disulfide bridge of tissue-nonspecific alkaline phosphatase with an Arg433-->Cys substitution associated with severe hypophosphatasia. The FEBS Journal. 2006;273:5612–5624
  74. Whyte MP, Vrabel LA, Schwartz TD. Adult hypophosphatasia: generalized deficiency of alkaline phosphatase activity demonstrated with cultured skin fibroblasts. Transactions of the Association of American Physicians. 1982;95:253–263
  75. Eastman JR, Bixler D. Clinical, laboratory, and genetic investigations of hypophosphatasia: support for autosomal dominant inheritance with homozygous lethality. Journal of Craniofacial Genetics and Developmental Biology. 1983;3:213–234
  76. Eberic FHS, H S, Pralle H, Kabish A. Adult hypophosphatasia without apparent skeletal disease: ‘ondotohypophosphatasia’ in four heterozygote members of a family. Klinische Wochenschrift. 1984;62:371
  77. Henthorn PS, Raducha M, Fedde KN, et al. Different missense mutations at the tissue-nonspecific alkaline phosphatase gene locus in autosomal recessively inherited forms of mild and severe hypophosphatasia. Proceedings of the National Academy of Sciences of the United States of America. 1992;89:9924–9928
  78. Muller HL, Yamazaki M, Michigami T, et al. Asp361Val Mutant of alkaline phosphatase found in patients with dominantly inherited hypophosphatasia inhibits the activity of the wild-type enzyme. The Journal of Clinical Endocrinology and Metabolism. 2000;85:743–747
  79. Hu JC, Plaetke R, Mornet E, et al. Characterization of a family with dominant hypophosphatasia. European Journal of Oral Sciences. 2000;108:189–194
  80. Herasse M, Spentchian M, Taillandier A, et al. Molecular study of three cases of odontohypophosphatasia resulting from heterozygosity for mutations in the tissue non-specific alkaline phosphatase gene. Journal of Medical Genetics. 2003;40:605–609
  81. Rasmussen K. Phosphorylethanolamine and hypophosphatasia. Danish Medical Bulletin. 1968;15:(Suppl. 2):1–112
  82. Watanabe A, Yamamasu S, Shinagawa T, et al. Prenatal genetic diagnosis of severe perinatal (lethal) hypophosphatasia. Journal of Nippon Medical School. 2007;74:65–69
  83. Henthorn PS, Whyte MP. Infantile hypophosphatasia: successful prenatal assessment by testing for tissue-non-specific alkaline phosphatase isoenzyme gene mutations. Prenatal Diagnosis. 1995;15:1001–1006
  84. Orimo H, Nakajima E, Hayashi Z, et al. First-trimester prenatal molecular diagnosis of infantile hypophosphatasia in a Japanese family. Prenatal Diagnosis. 1996;16:559–563
  85. Mornet E, Muller F, Ngo S, et al. Correlation of alkaline phosphatase (ALP) determination and analysis of the tissue non-specific ALP gene in prenatal diagnosis of severe hypophosphatasia. Prenatal Diagnosis. 1999;19:755–757
  86. Fraser D. Hypophosphatasia. The American Journal of Medicine. 1957;22:730–746
  87. Wenkert D, Podgornik MN, Coburn SP et al. Dietary phosphate restriction therapy for hypophosphatasia: preliminary observations. In: Fifth international alkaline phosphatase symposium: ‘understanding alkaline phosphatase function – pathophysiology and treatment of hypophosphatasia and other AP-related diseases’. Huningue, France; 2007.
  88. Girschick HJ, Seyberth HW, Huppertz HI. Treatment of childhood hypophosphatasia with nonsteroidal antiinflammatory drugs. Bone. 1999;25:603–607
  89. Girschick HJ, Schneider P, Haubitz I, et al. Effective NSAID treatment indicates that hyperprostaglandinism is affecting the clinical severity of childhood hypophosphatasia. Orphanet Journal of Rare Diseases. 2006;1:24
  90. Whyte MP, Mumm S, Deal C. Adult hypophosphatasia treated with teriparatide. The Journal of Clinical Endocrinology and Metabolism. 2007;92:1203–1208
  91. Whyte MP, Kurtzberg J, McAlister WH, et al. Marrow cell transplantation for infantile hypophosphatasia. Journal of Bone and Mineral Research. 2003;18:624–636
  92. Cahill RA, Wenkert D, Perlman SA, et al. Infantile hypophosphatasia: transplantation therapy trial using bone fragments and cultured osteoblasts. The Journal of Clinical Endocrinology and Metabolism. 2007;92:2923–2930
  93. Antonarakis SE. Recommendations for a nomenclature system for human gene mutations. Nomenclature Working Group. Human Mutation. 1998;11:1–3
  94. Millán JL, Narisawa S, Lemire I, et al. Enzyme replacement therapy for murine hypophosphatasia. J Bone Miner Res. 2007 Dec 17;

PII: S1521-6942(07)00126-X

doi: 10.1016/j.berh.2007.11.003

Best Practice & Research Clinical Rheumatology
Volume 22, Issue 1 , Pages 113-127 , March 2008

Article Tools

* Image Usage & Resolution